Similar Articles
311 Liver manifestations and complications in inflammatory bowel disease: A review
312 Real-world data on the infliximab biosimilar CT-P13 (Remsima®) in inflammatory bowel disease
313 Clinical significance of signet ring cells in surgical esophageal and esophagogastric junction adenocarcinoma: A systematic review and meta-analysis
314 Percutaneous biliary stent combined with brachytherapy using 125I seeds for treatment of unresectable malignant obstructive jaundice: A meta-analysis
315 Intracuff alkalinized lidocaine to prevent postoperative airway complications: A meta-analysis
316 Remission is not maintained over 2 years with hematopoietic stem cell transplantation for rheumatoid arthritis: A systematic review with meta-analysis
317 Liver involvement in inflammatory bowel disease: What should the clinician know?
318 Prognostic value of ground glass opacity on computed tomography in pathological stage I pulmonary adenocarcinoma: A meta-analysis
319 Antimicrobial peptides and the gut microbiome in inflammatory bowel disease
320 Minimum sample size estimates for trials in inflammatory bowel disease: A systematic review of a support resource
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA